ZA923735B - Essential pure human parathyroid hormone - Google Patents

Essential pure human parathyroid hormone

Info

Publication number
ZA923735B
ZA923735B ZA923735A ZA923735A ZA923735B ZA 923735 B ZA923735 B ZA 923735B ZA 923735 A ZA923735 A ZA 923735A ZA 923735 A ZA923735 A ZA 923735A ZA 923735 B ZA923735 B ZA 923735B
Authority
ZA
South Africa
Prior art keywords
parathyroid hormone
human parathyroid
pure human
essential pure
essential
Prior art date
Application number
ZA923735A
Other languages
English (en)
Inventor
Dennis R Sindrey
R Sindrey Dennis
Original Assignee
Allelix Biopharma
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24840399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA923735(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allelix Biopharma, Glaxo Canada filed Critical Allelix Biopharma
Publication of ZA923735B publication Critical patent/ZA923735B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA923735A 1991-05-23 1992-05-22 Essential pure human parathyroid hormone ZA923735B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/707,114 US5208041A (en) 1991-05-23 1991-05-23 Essentially pure human parathyroid hormone

Publications (1)

Publication Number Publication Date
ZA923735B true ZA923735B (en) 1993-01-27

Family

ID=24840399

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923735A ZA923735B (en) 1991-05-23 1992-05-22 Essential pure human parathyroid hormone

Country Status (16)

Country Link
US (1) US5208041A (es)
EP (1) EP0515228B1 (es)
JP (1) JP2563726B2 (es)
KR (1) KR970007755B1 (es)
AT (1) ATE164394T1 (es)
CA (1) CA2068438C (es)
DE (1) DE69224858T2 (es)
DK (1) DK0515228T3 (es)
ES (1) ES2115642T3 (es)
FI (1) FI106802B (es)
HK (1) HK1004340A1 (es)
IE (1) IE921672A1 (es)
IL (3) IL119840A (es)
NO (2) NO304190B1 (es)
NZ (1) NZ242855A (es)
ZA (1) ZA923735B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
AU8002994A (en) * 1993-10-27 1995-05-22 Chugai Seiyaku Kabushiki Kaisha Cure accelerator in chondroplasty
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US20020193338A1 (en) * 1994-02-18 2002-12-19 Goldstein Steven A. In vivo gene transfer methods for wound healing
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US6074840A (en) 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
CA2297489A1 (en) 1997-07-30 1999-02-11 Emory University Novel bone mineralization proteins, dna, vectors, expression systems
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
DZ2873A1 (fr) 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
WO2000023594A1 (en) * 1998-10-22 2000-04-27 The General Hospital Corporation BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
AU4217299A (en) 1998-11-30 2000-06-19 General Hospital Corporation, The Pth1r and pth3r receptors, methods and uses thereof
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
US7893021B2 (en) * 1999-06-02 2011-02-22 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
CA2414966A1 (en) 2000-06-30 2002-01-10 Suntory Limited A pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration containing the component
US6387711B1 (en) * 2000-08-11 2002-05-14 Quest Diagnostics Investments Incorporated Liquid intact parathyroid hormone (PTH) standards
US6905886B2 (en) * 2000-08-11 2005-06-14 Quest Diagnostics Investments Incorporated Preservative solutions
AU2002339843B2 (en) * 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
US20040067526A1 (en) * 2002-10-03 2004-04-08 Cantor Thomas L. Methods for diagnosing and guiding treatment of bone turnover disease
JP4334480B2 (ja) * 2003-03-19 2009-09-30 ザ ジェネラル ホスピタル コーポレイション α−ヘリックス安定化剤を用いる高次構造的に制約された副甲状腺ホルモン
KR100540659B1 (ko) * 2003-07-02 2006-01-10 삼성전자주식회사 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체
WO2005009358A2 (en) 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
EP1744683B1 (en) * 2004-05-13 2016-03-16 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US7541140B2 (en) * 2004-06-03 2009-06-02 Scantibodies Laboratory, Inc. Assessing risk for kidney stones using parathyroid hormone agonist and antagonist
AU2006315132A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US8143374B2 (en) * 2006-08-04 2012-03-27 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (PTH)
EP2187902B1 (en) * 2007-08-01 2013-04-17 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
EP2173768B1 (en) * 2007-08-09 2014-03-05 USV Limited Novel orthogonal process for purification of recombinant human parathyroid hormone (rhpth) (1-34)
ES2625125T3 (es) * 2009-08-11 2017-07-18 Biocon Limited Procesos cromatográficos
US8987201B2 (en) 2009-12-07 2015-03-24 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
WO2011143406A2 (en) 2010-05-13 2011-11-17 The General Hospital Corporation Parathyroid hormone analogs and uses thereof
KR20150116468A (ko) 2011-06-07 2015-10-15 아사히 가세이 파마 가부시키가이샤 고순도 ｐｔｈ 함유 동결 건조 제제 및 그의 제조 방법
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
LU100168B1 (en) 2017-04-12 2018-10-15 Michael Pazianas Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease
EP4110370A4 (en) 2020-03-30 2023-06-07 Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. FORMULATIONS OF HUMAN PARATHYROID HORMONE (PTH) AND METHODS OF MANUFACTURE THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
WO1991005050A1 (en) * 1989-09-29 1991-04-18 Her Majesty In Right Of Canada As Represented By The National Research Council Of Canada Synthesis of mature human parathyroid hormone

Also Published As

Publication number Publication date
FI922356A (fi) 1992-11-24
HK1004340A1 (en) 1998-11-20
NO2006013I2 (no) 2009-12-07
IL101829A (en) 1999-12-31
IL119840A (en) 2005-08-31
DE69224858D1 (de) 1998-04-30
ATE164394T1 (de) 1998-04-15
KR970007755B1 (en) 1997-05-16
ES2115642T3 (es) 1998-07-01
CA2068438A1 (en) 1992-11-24
AU1604992A (en) 1993-03-11
IL119840A0 (en) 1997-03-18
EP0515228A3 (es) 1994-05-04
DK0515228T3 (da) 1998-09-28
JP2563726B2 (ja) 1996-12-18
NO922000D0 (no) 1992-05-21
NO2006013I1 (no) 2006-11-06
DE69224858T2 (de) 1998-07-23
JPH0687897A (ja) 1994-03-29
AU639856B2 (en) 1993-08-05
NZ242855A (en) 1994-04-27
IL101829A0 (en) 1992-12-30
FI106802B (fi) 2001-04-12
IE921672A1 (en) 1992-12-02
NO922000L (no) 1992-11-24
NO304190B1 (no) 1998-11-09
US5208041A (en) 1993-05-04
EP0515228B1 (en) 1998-03-25
CA2068438C (en) 1996-11-12
FI922356A0 (fi) 1992-05-22
EP0515228A2 (en) 1992-11-25

Similar Documents

Publication Publication Date Title
KR970007755B1 (en) Essential pure human parathyroid hormone
DE3876273D1 (de) Isoelektrisches fokussierverfahren sowie einrichtung zur durchfuehrung dieses verfahrens.
DE69405102D1 (en) Antikoerperfragmente in therapie
IE862390L (en) Cleaning and disinfecting contact lenses
EP0213105A3 (en) Method for assembling an optoisolator and leadframe therefor
DE3680997D1 (de) Einrichtung zur als sprache empfundenen rueckkopplung.
IT8221194A0 (it) Procedimento e dispositivo per la deformazione dei corpi di lattine e dispositivo per l'esecuzione di questo procedimento.
FI864654A (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
ATE72833T1 (de) Rinder-prowachstums- und -wachstumshormon.
EP0259816A3 (en) Method for bonding semiconductor laser element and apparatus therefor
EP0168030A3 (en) Contact type image sensor and driving method therefor
AU577692B2 (en) Lorgnette frame
GB8820058D0 (en) Mosfet & fabrication method
EP0196405A3 (en) Color picture reader and method for operating the same
GR851623B (es)
IT8467198A1 (it) Metodo e dispositivo per il controllo dei processi di saldatura mediante l'analisi della luminosita' generata durante il processo.
HU900822D0 (en) Trichoderma-fungus and fungicid containing it
GB2216262B (en) Method for measuring and controlling ozone concentration
IT8619414A0 (it) Apparato e metodo per la sovrapposizione di immagini video.
JPS6465184A (en) Method for sealing epoxy fluorinated carbon
IE852396L (en) Field effect transistor current source
PL273538A1 (en) Method for controlling operation of current sopurce in a magnetic-powder defectoscope excitation device and a system for controlling the current source of a magnetic-powder defectoscope excitation device
MY8500371A (en) A method and apparatus for determining the concentration of a carbon source of an-l amino acid